Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer

被引：0
|
作者：
Pauline Corbaux
Audrey Lardy-Cleaud
Marie Alexandre
Maxime Fontanilles
Christelle Lévy
Alessandro Adriano Viansone
Audrey Mailliez
Marc Debled
Anthony Goncalves
Fanny Le Du
Florence Lerebours
Jean-Marc Ferrero
Jean-Christophe Eymard
Marie-Ange Mouret-Reynier
Thierry Petit
Jean-Sébastien Frenel
Florence Dalenc
Coralie Courtinard
Marie Chaix
Thomas Bachelot
机构：
[1] Centre Léon Bérard,Department of Medical Oncology
[2] Centre Léon Bérard,Biostatistics Unit, DRCI
[3] Institut Régional du Cancer de Montpellier,Department of Medical Oncology
[4] Centre Henri Becquerel,Department of Medical Oncology
[5] Centre François Baclesse,Department of Medical Oncology
[6] Institut Gustave Roussy,Department of Cancer Medicine
[7] Centre Oscar Lambret,Department of Medical Oncology
[8] Institut Bergonié,Department of Medical Oncology
[9] Institut Paoli-Calmettes,Department of Medical Oncology
[10] Centre Eugène Marquis,Department of Medical Oncology
[11] Institut Curie,Department of Medical Oncology
[12] Centre Antoine Lacassagne,Department of Medical Oncology
[13] Institut Jean Godinot,Department of Medical Oncology
[14] Centre Jean Perrin,Department of Medical Oncology
[15] Centre Paul Strauss,Department of Medical Oncology
[16] Institut de Cancérologie de l’Ouest René Gauducheau,Department of Medical Oncology
[17] Institut Claudius Regaud—IUCT Oncopole,Department of Medical Oncology
[18] Unicancer,Data Office
[19] Université de Bordeaux,Inserm, Bordeaux Population Health Research Center, Epicene Team, UMR 1219
[20] Centre Hospitalier Universitaire Dijon Bourgogne,Department of Medical Oncology
来源：
Breast Cancer Research and Treatment | 2022年 / 191卷
关键词：
Advanced breast cancer; HR+/HER2−; Endocrine therapy; Chemotherapy; Progression-free survival; Real-word data;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：191 / 207
页数：16
相关论文
共 50 条
  • [31] Molecular classification of hormone receptor-positive HER2-negative breast cancer
    Jin, Xi
    Zhou, Yi-Fan
    Ma, Ding
    Zhao, Shen
    Lin, Cai-Jin
    Xiao, Yi
    Fu, Tong
    Liu, Cheng-Lin
    Chen, Yi-Yu
    Xiao, Wen-Xuan
    Liu, Ya-Qing
    Chen, Qing-Wang
    Yu, Ying
    Shi, Le-Ming
    Shi, Jin-Xiu
    Huang, Wei
    Robertson, John F. R.
    Jiang, Yi-Zhou
    Shao, Zhi-Ming
    NATURE GENETICS, 2023, 55 (10) : 1696 - +
  • [32] Management of hormone receptor-positive, HER2-negative early breast cancer
    Walsh, Elaine M.
    Smith, Karen L.
    Stearns, Vered
    SEMINARS IN ONCOLOGY, 2020, 47 (04) : 187 - 200
  • [33] Molecular classification of hormone receptor-positive HER2-negative breast cancer
    Xi Jin
    Yi-Fan Zhou
    Ding Ma
    Shen Zhao
    Cai-Jin Lin
    Yi Xiao
    Tong Fu
    Cheng-Lin Liu
    Yi-Yu Chen
    Wen-Xuan Xiao
    Ya-Qing Liu
    Qing-Wang Chen
    Ying Yu
    Le-Ming Shi
    Jin-Xiu Shi
    Wei Huang
    John F. R. Robertson
    Yi-Zhou Jiang
    Zhi-Ming Shao
    Nature Genetics, 2023, 55 : 1696 - 1708
  • [34] Optimizing care for younger women with hormone receptor-positive, HER2-negative metastatic breast cancer
    de Boer, Richard
    Hui, Rina
    Lim, Elgene
    Yeo, Belinda
    Zdenkowski, Nicholas
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 3 - 14
  • [35] Alternative Palbociclib Dosing Schedules for Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer
    Go, Makiko
    Kimura, Michio
    Yamada, Shiori
    Kamei, Keitaro
    Noguchi, Yoshinori
    Usami, Eiseki
    Yoshimura, Tomoaki
    ONCOLOGY, 2024,
  • [36] Treatment differences by race and age in metastatic hormone receptor-positive/HER2-negative breast cancer
    Abdou, Yara
    Ivory, Joannie
    Deal, Allison
    Wardell, Ally
    Wheless, Amy
    Dees, Claire
    Carey, Lisa
    CANCER RESEARCH, 2024, 84 (09)
  • [37] Challenges in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer with brain metastases
    Minetta C. Liu
    Javier Cortés
    Joyce O’Shaughnessy
    Cancer and Metastasis Reviews, 2016, 35 : 323 - 332
  • [38] Challenges in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer with brain metastases
    Liu, Minetta C.
    Cortes, Javier
    O'Shaughnessy, Joyce
    CANCER AND METASTASIS REVIEWS, 2016, 35 (02) : 323 - 332
  • [39] Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study
    Martin, Miguel
    Zielinski, Christoph
    Ruiz-Borrego, Manuel
    Carrasco, Eva
    Ciruelos, Eva M.
    Munoz, Montserrat
    Bermejo, Begona
    Margeli, Mireia
    Csoszi, Tibor
    Anton, Antonio
    Turner, Nicholas
    Casas, Maria, I
    Morales, Serafin
    Alba, Emilio
    Calvo, Lourdes
    De La Haba-Rodriguez, Juan
    Ramos, Manuel
    Murillo, Laura
    Santaballa, Ana
    Alonso-Romero, Jose L.
    Sanchez-Rovira, Pedro
    Corsaro, Massimo
    Huang, Xin
    Thallinger, Christiane
    Kahan, Zsuzsanna
    Gil-Gil, Miguel
    EUROPEAN JOURNAL OF CANCER, 2022, 168 : 12 - 24
  • [40] Patterns of chemotherapy receipt among patients with hormone receptor-positive, HER2-negative breast cancer
    Linnea T. Olsson
    Alina M. Hamilton
    Sarah C. Van Alsten
    Jennifer L. Lund
    Til Stürmer
    Hazel B. Nichols
    Katherine E. Reeder-Hayes
    Melissa A. Troester
    Breast Cancer Research and Treatment, 2024, 204 : 107 - 116
12345